New Delhi-based Akums Drugs & Pharmaceuticals, a leading contract development and manufacturing organisation (CDMO), has announced the appointment of Amrut Medhekar as the Chief Executive Officer (CEO) of its CDMO business, effective August 24, 2024.

Medhekar, who will report to Sanjeev Jain and Sandeep Jain, the Joint Managing Directors of Akums, brings over 27 years of extensive experience in the pharmaceutical industry. His expertise spans corporate strategy, business leadership, key account management, portfolio strategy and supply management.

Before joining Akums, Medhekar held the position of President of India Business at Wockhardt, where he spearheaded significant growth initiatives. His also spend considerable time of his career at the Zydus Group, along with key roles at Novartis, JK Tyre and Industries, Life Medicare Biotech, Torrent Pharmaceuticals and Ranbaxy.

Medhekar brings a robust academic background, including an Executive MBA from IIM Ahmedabad, an Executive Program in Finance from XLRI, and a Management Development Program (MDP) from MDI Gurgaon. He also holds a Bachelor's degree in Science from Jiwaji University, Gwalior. In addition to his academic credentials, Amrut has served as a Jury Member for the HULT Prize $1M Challenge at IIM Ahmedabad and has been an honorary speaker at various prestigious management institutes, including FMS, Symbiosis, AIMA, and UpGrad.

Medhekar’s proven track record of leadership and innovation in the pharmaceutical sector positions him to drive Akums’ CDMO business to new heights.